| Total-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancers (NCT00003572) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1998-08-01 |
| Chemotherapy Plus Radiation Therapy in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma (NCT00003631) | Memorial Sloan Kettering Cancer Center | 1998-08-01 |
| A Study for Aggressive Adult T-cell Leukemia-lymphoma (ATLL) (NCT00145002) | Japan Clinical Oncology Group | 1998-08-01 |
| Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation (NCT00003887) | Fred Hutchinson Cancer Center | 1998-08-01 |
| 506U78 in Treating Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma (NCT00003545) | National Cancer Institute (NCI) | 1998-08-01 |
| Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer (NCT00003451) | National Cancer Institute (NCI) | 1998-08-01 |
| Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas (NCT00019513) | National Institutes of Health Clinical Center (CC) | 1998-08-01 |
| Treatment for Chronic Pain in Patients With Advanced Cancer (NCT00003687) | NCIC Clinical Trials Group | 1998-06-11 |
| Combination Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma (NCT00003541) | Memorial Sloan Kettering Cancer Center | 1998-06-01 |
| Irinotecan in Treating Patients With Solid Tumors or Lymphoma Who Have Abnormal Liver or Kidney Function or Who Have Received Radiation Therapy to the Pelvis (NCT00003368) | National Cancer Institute (NCI) | 1998-06-01 |
| Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer (NCT00003661) | Roswell Park Cancer Institute | 1998-06-01 |
| Combination Chemotherapy Plus Interferon Alfa or Rituximab in Treating Patients With Stage III or Stage IV Lymphoma (NCT00004039) | Hoag Memorial Hospital Presbyterian | 1998-06-01 |
| UCN-01 in Treating Patients With Advanced Cancer (NCT00003289) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1998-06-01 |
| Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Disease (NCT00003421) | Medical Research Council | 1998-06-01 |
| HLA-Mismatched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematological Malignancies (NCT00001748) | National Heart, Lung, and Blood Institute (NHLBI) | 1998-06-01 |
| Rituximab and Dexamethasone in Treating Patients With Recurrent or Refractory Indolent Non-Hodgkin's Lymphoma (NCT00003663) | Hoag Memorial Hospital Presbyterian | 1998-06-01 |
| Dolastatin 10 in Treating Patients With Indolent Lymphoma, Waldenstrom's Macroglobulinemia, or Chronic Lymphocytic Leukemia (NCT00005579) | University of Vermont | 1998-06-01 |
| Chemotherapy, Filgrastim, and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma (NCT00003929) | Case Comprehensive Cancer Center | 1998-06-01 |
| Combination Chemotherapy in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma (NCT00003311) | M.D. Anderson Cancer Center | 1998-05-20 |
| Rituxan and BEAM With Autologous Peripheral Blood Progenitor Transplant for Indolent Lymphoma (NCT00572013) | University of Nebraska | 1998-05-12 |
| Temozolomide in Treating Patients With Mycosis Fungoides or Sezary Syndrome (NCT00004106) | Northwestern University | 1998-05-01 |
| Rituximab Plus Cyclophosphamide in Treating Patients With Indolent Stage III or Stage IV Non-Hodgkin's Lymphoma (NCT00003605) | Hoag Memorial Hospital Presbyterian | 1998-05-01 |
| Melphalan With BBBD in Treating Patients With Brain Malignancies (NCT00253721) | OHSU Knight Cancer Institute | 1998-05-01 |
| Antiviral Therapy Plus Either Peripheral Stem Cell or Umbilical Cord Blood Transplantation in Treating Patients Who Are HIV Positive and Have Hematologic Cancer (NCT00003435) | Duke University | 1998-05-01 |
| Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer (NCT00003408) | Cancer Treatment Centers of America | 1998-04-01 |
| Arsenic Trioxide in Treating Patients With Advanced Hematologic Cancer (NCT00003395) | Memorial Sloan Kettering Cancer Center | 1998-04-01 |
| High-Dose Chemotherapy in Treating Patients Undergoing Stem Cell Transplant for Recurrent or Refractory Hodgkin's Lymphoma (NCT00544570) | City of Hope Medical Center | 1998-04-01 |
| Interleukin-2 Following Bone Marrow Transplantation in Treating Patients With Hematologic Cancer (NCT00003962) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1998-04-01 |
| Combination Chemotherapy Followed by Donor Bone Marrow Transplant or Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Genetic Disorders (NCT00008307) | Herbert Irving Comprehensive Cancer Center | 1998-04-01 |
| Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Leukemia (NCT00004084) | Garden State Cancer Center at the Center for Molecular Medicine and Immunology | 1998-04-01 |
| Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Recurrent or Refractory Hodgkin's or Non-Hodgkin's Lymphoma (NCT00002941) | Children's Oncology Group | 1998-04-01 |
| Evaluation, Treatment, and Natural History of Children and Young Adults With Cancer or Rare Diseases (NCT00001686) | National Cancer Institute (NCI) | 1998-03-19 |
| Fludarabine, Mitoxantrone, and Dexamethasone (FND) Plus Rituximab for Lymphoma Patients (NCT00577993) | M.D. Anderson Cancer Center | 1998-03-16 |
| Combination Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin's Lymphoma (NCT00049439) | Case Comprehensive Cancer Center | 1998-03-01 |
| Combination Chemotherapy in Treating Children With Stage III or Stage IV Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia (NCT00003217) | Children's Oncology Group | 1998-03-01 |
| Radiation Therapy and High-Dose Corticosteroids in Treating Older Patients With Primary CNS Non-Hodgkin's Lymphoma (NCT00003278) | Alliance for Clinical Trials in Oncology | 1998-03-01 |
| Monoclonal Antibody Therapy in Treating Patients With Lymphoproliferative Disorder Associated With Immunosuppression Therapy (NCT00003716) | Stanford University | 1998-03-01 |
| Irinotecan in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma (NCT00003245) | M.D. Anderson Cancer Center | 1998-02-18 |
| Fludarabine Plus Octreotide in Treating Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma (NCT00002779) | Alliance for Clinical Trials in Oncology | 1998-02-01 |
| Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors (NCT00003269) | Scripps Health | 1998-02-01 |
| Radiolabeled Monoclonal Antibody Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Lymphoma or Waldenstrom's Macroglobulinemia (NCT00004107) | Garden State Cancer Center at the Center for Molecular Medicine and Immunology | 1998-02-01 |
| Combination Chemotherapy in Treating Patients With Advanced Cancer (NCT00003331) | NYU Langone Health | 1998-01-01 |
| Monoclonal Antibody Therapy in Treating Patients With Follicular or Mantle Cell Lymphoma (NCT00003280) | Swiss Cancer Institute | 1998-01-01 |
| Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic Cancer (NCT00003335) | Case Comprehensive Cancer Center | 1998-01-01 |
| Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer (NCT00006368) | Novartis Pharmaceuticals | 1998-01-01 |
| Combination Chemotherapy Plus Infusion of White Blood Cells in Treating Patients With Hematologic Cancer (NCT00003243) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1998-01-01 |
| Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Older Patients With Non-Hodgkin's Lymphoma (NCT00003150) | Eastern Cooperative Oncology Group | 1997-12-01 |
| Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer (NCT00003082) | University of Arizona | 1997-12-01 |
| Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect (NCT00003425) | University of Kentucky | 1997-12-01 |
| Combination Chemotherapy With or Without Amifostine in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's Disease Undergoing Stem Cell Transplantation (NCT00003143) | Jonsson Comprehensive Cancer Center | 1997-11-01 |
| Arsenic Trioxide in Treating Patients With Recurrent or Refractory Acute Leukemia, Chronic Myeloide Leukemia, Myelodysplasia, Lymphoma, or Myeloma (NCT00003885) | Our Lady of Mercy Medical Center | 1997-11-01 |
| Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer (NCT00004036) | The Cleveland Clinic | 1997-11-01 |
| Rituximab Plus Interleukin-2 in Treating Patients With Lymphoma (NCT00003356) | University of Rochester | 1997-11-01 |
| Rituximab After Autologous Stem Cell Transplant for Relapsed B-cell Non-Hodgkin's Lymphoma (NCT00225212) | Stanford University | 1997-11-01 |
| Penclomedine in Treating Patients With Solid Tumors or Lymphoma (NCT00002946) | National Cancer Institute (NCI) | 1997-10-01 |
| Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's Disease (NCT00003414) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1997-10-01 |
| Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors (NCT00003107) | Indiana University | 1997-10-01 |
| S9704-S0014-S0313A Studying Genes in Samples From Patients With Limited or Advanced Diffuse Large B-Cell Lymphoma (NCT01563861) | SWOG Cancer Research Network | 1997-09-15 |
| Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer (NCT00003270) | Roswell Park Cancer Institute | 1997-09-04 |
| Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Other B-cell Cancers (NCT00003163) | Medical College of Wisconsin | 1997-09-01 |
| Flavopiridol in Treating Patients With Recurrent Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma or Mantle Cell Lymphoma (NCT00003039) | National Cancer Institute (NCI) | 1997-09-01 |
| Antibiotic Therapy in Treating Patients With Low Grade Gastric Lymphoma (NCT00003151) | European Organisation for Research and Treatment of Cancer - EORTC | 1997-09-01 |
| Bryostatin 1 and High Dose Cytarabine in Treating Patients With Refractory or Relapsed Leukemia or Lymphoma (NCT00003079) | Virginia Commonwealth University | 1997-09-01 |
| Flavopiridol in Treating Patients With Refractory Cancer (NCT00019344) | National Cancer Institute (NCI) | 1997-08-01 |
| Depsipeptide in Treating Patients With Solid Tumors (NCT00019318) | National Cancer Institute (NCI) | 1997-08-01 |
| Bleomycin in Treating Patients With Non-Hodgkin's Lymphoma (NCT00003110) | Case Comprehensive Cancer Center | 1997-07-01 |
| Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Primary CNS Lymphoma (NCT00003061) | European Organisation for Research and Treatment of Cancer - EORTC | 1997-07-01 |
| SWOG-9704 Chemoradiotherapy and Peripheral Stem Cell Transplantation Compared With Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma (NCT00004031) | SWOG Cancer Research Network | 1997-07-01 |
| Oral Combination Chemotherapy in Treating Elderly Patients With Intermediate or High-Grade Non-Hodgkin's Lymphomas (NCT00003113) | Case Comprehensive Cancer Center | 1997-07-01 |
| Combination Chemotherapy in Treating Patients With AIDS-Related Hodgkin's Disease (NCT00003114) | Case Comprehensive Cancer Center | 1997-07-01 |
| Radiolabeled Monoclonal Antibody, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory B-Cell Cancer (NCT00004086) | Garden State Cancer Center at the Center for Molecular Medicine and Immunology | 1997-06-01 |
| Liposomal Doxorubicin Plus Combination Chemotherapy in Treating Patients With AIDS-Associated Non-Hodgkin's Lymphoma (NCT00004162) | University of Alabama at Birmingham | 1997-06-01 |
| A Phase I Trial of 5-Fluorouracil Given With 776C85 (GW776) and Low-Dose Leucovorin in Adult Patients With Solid Tumors (NCT00001579) | National Cancer Institute (NCI) | 1997-06-01 |
| Combination Chemotherapy in Treating Patients With Hodgkin's Disease and HIV Infection (NCT00003262) | Centro di Riferimento Oncologico - Aviano | 1997-05-01 |
| Decitabine in Treating Patients With Melanoma or Other Advanced Cancer (NCT00002980) | California Cancer Consortium | 1997-05-01 |
| Chemotherapy Given With Amifostine and Filgrastim in Treating Patients With Recurrent or Metastatic Cancer (NCT00003294) | Roswell Park Cancer Institute | 1997-05-01 |
| Chemotherapy and Radiation Therapy in Treating Patients With HIV-Related Primary Central Nervous System Lymphoma (NCT00003261) | Centro di Riferimento Oncologico - Aviano | 1997-05-01 |
| Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation (NCT00003056) | Baxalta now part of Shire | 1997-04-01 |
| Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Aggressive Non-Hodgkin's Lymphoma (NCT00003215) | Swiss Cancer Institute | 1997-04-01 |
| Interleukin-2 in Treating Patients With Mycosis Fungoides or Sezary Syndrome (NCT00005788) | Northwestern University | 1997-04-01 |
| Radiolabeled Monoclonal Antibody in the Detection and Staging of Patients With Non-Hodgkin's Lymphoma (NCT00003337) | Gilead Sciences | 1997-03-01 |
| Combination Chemotherapy With or Without Dexrazoxane in Treating Children With Hodgkin's Disease (NCT00005578) | Children's Oncology Group | 1997-03-01 |
| Chemotherapy Plus Interferon Alfa Alone or With Radiation Therapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Follicular Non-Hodgkin's Lymphoma (NCT00003152) | European Organisation for Research and Treatment of Cancer - EORTC | 1997-03-01 |
| Monoclonal Antibodies in Detecting Residual Disease in Patients Who Have Been Treated for Non-Hodgkin's Lymphoma (NCT00003338) | Gilead Sciences | 1997-03-01 |
| Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome (NCT00002989) | European Organisation for Research and Treatment of Cancer - EORTC | 1997-03-01 |
| Chemotherapy in Treating Young Patients With Recurrent or Refractory Meningeal Leukemia, Lymphoma, or Solid Tumors (NCT00003073) | Pacira Pharmaceuticals, Inc | 1997-02-01 |
| Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma (NCT00003650) | UNICANCER | 1997-02-01 |
| Phenylbutyrate in Treating Patients With Refractory Solid Tumors or Lymphoma (NCT00002909) | National Cancer Institute (NCI) | 1997-02-01 |
| Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Older Patients With Refractory or Relapsed Intermediate-Grade Non-Hodgkin's Lymphoma (NCT00002982) | Memorial Sloan Kettering Cancer Center | 1997-01-01 |
| Genetic Study in Patients Receiving Treatment for Hodgkin's Disease or Childhood Brain Tumor (NCT00006342) | Duke University | 1997-01-01 |
| Combination Chemotherapy Given With Radiation Therapy or Radiation Therapy Alone in Treating Patients With Early-Stage Hodgkin's Disease (NCT00002987) | Medical Research Council | 1997-01-01 |
| Umbilical Cord Blood and Placental Blood Transplantation in Treating Patients With Hematologic Cancer or Aplastic Anemia (NCT00008164) | Herbert Irving Comprehensive Cancer Center | 1997-01-01 |
| Clinical, Laboratory and Epidemiologic Pilot Studies of Individuals at High Risk for Viral-Associated Cancers (NCT00001560) | National Cancer Institute (NCI) | 1996-12-24 |
| Bryostatin 1 in Treating Patients With Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia (NCT00002908) | Barbara Ann Karmanos Cancer Institute | 1996-12-01 |
| Etoposide in Treating Patients With Relapsed Non-Hodgkin's Lymphoma (NCT00002880) | Alliance for Clinical Trials in Oncology | 1996-11-01 |
| Immunotherapy for Lymphoproliferative Diseases Associated With Epstein-Barr Virus in Patients Who Have Undergone Organ Transplants (NCT00002956) | University of Alabama at Birmingham | 1996-11-01 |
| Cladribine in Patients With Mantle Cell Lymphoma (NCT00002879) | Alliance for Clinical Trials in Oncology | 1996-11-01 |
| Perillyl Alcohol in Treating Patients With Refractory Cancer (NCT00002862) | National Cancer Institute (NCI) | 1996-10-01 |
| Monoclonal Antibody Therapy in Treating Patients With Leukemia (NCT00019227) | National Cancer Institute (NCI) | 1996-10-01 |
| Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Disease (NCT00002827) | Children's Oncology Group | 1996-10-01 |